For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Genentech, Inc.

USPTO Granted Patents = 3,224

CIPO Patents = 158

EPO Patents = 589

Trademarks = 103

Forward Citations = 67,285

Loading Chart...

Loading Chart...

2,488 inventors (with patents filed for the assignee):

William I Wood (641 out of 667 patents)

Austin L Gurney (611 out of 719 patents)

Audrey Goddard (600 out of 632 patents)

4. Paul J Godowski (568 out of 594 patents)

5. Victoria Smith (285 out of 312 patents)

6. Colin K Watanabe (204 out of 213 patents)

7. J Christopher Grimaldi (138 out of 145 patents)

8. Leonard G Presta (121 out of 211 patents)

9. Luc Roland Desnoyers (116 out of 141 patents)

10. Yan Wu (102 out of 111 patents)

11. Napoleone Ferrara (92 out of 105 patents)

12. Mark S Dennis (84 out of 97 patents)

13. Kevin P Baker (76 out of 92 patents)

14. Henry Bernard Lowman (74 out of 94 patents)

15. Avi J Ashkenazi (73 out of 78 patents)

Core Competencies:

Hybridoma Platform

Therapeutic Antibody Discovery

Lesion Segmentation

Isoquinoline Compounds

Deep Learning

Subcutaneous Antibody Formulations

Combination Therapy

Pharmaceutical Compositions

Immunogenic Peptides

Image Processing

Cyclic Peptide Antibiotics

Protein Production

3,224 patents: Sort by Forward Citations

1. 12517702 - Continuous integration and development of code in a secure environment (2026-01-06),

2. 12511742 - Connected machine-learning models with joint training for lesion detection (2025-12-30),

3. 12502141 - Neural network processing of OCT data to generate predictions of geographic-atrophy growth rates (2025-12-23),

4. 12488465 - Weakly supervised lesion segmentation (2025-12-02),

5. 12486315 - Developing an efficient hybridoma platform for therapeutic antibody discovery (2025-12-02),

6. 12479883 - Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform (2025-11-25),

7. 12478552 - Closure system and kit (2025-11-25),

8. 12475976 - Population PK/PD linking parameter analysis using deep learning (2025-11-18),

9. 12473301 - Isoquinoline compounds for the treatment of cancer (2025-11-18),

10. 12465551 - Closure system and kit (2025-11-11),

11. D1101145 - Ocular incision guide tool (2025-11-04),

12. 12459957 - Therapeutic compounds and methods (2025-11-04),

13. 12456190 - Automated assessment of endoscopic disease (2025-10-28),

14. 12448386 - Processes for the preparation of substituted 1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indoles (2025-10-21),

15. 12444477 - Antibody selection apparatus and methods (2025-10-14),

Genentech, Inc. is a leading biotechnology company specializing in the development of innovative pharmaceutical products to address significant unmet medical needs. Established in 1976, Genentech has been at the forefront of biotechnology advancements, focusing on groundbreaking research and pioneering the use of genetic engineering to develop highly effective drugs. Headquartered in South San Francisco, California, Genentech operates as a subsidiary of Roche Holding AG, a global healthcare company. With a portfolio of groundbreaking treatments in areas like oncology, immunology, and neuroscience, Genentech is committed to improving patients' lives and transforming the future of medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

3,224 Patents

#1 in South San Francisco, CA

#33 in California

#133 in US

#279 in the World

South San Francisco, CA, United States of America

Genentech, Inc.

Forward Citations = 67,285

2,488 inventors:

William I Wood (641 out of 667 patents)

Austin L Gurney (611 out of 719 patents)

Audrey Goddard (600 out of 632 patents)

4. Paul J Godowski (568 out of 594 patents)

5. Victoria Smith (285 out of 312 patents)

Please report any incorrect information to support@idiyas.com

Loading…